Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)
China · Delayed Price · Currency is CNY 7.92
+0.72 (10.00%)
Aug 4, 2026, 3:00 PM CST
SHA:600721 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 358.59 | 388.32 | 385.76 | 369.28 | 349.88 | 281.35 |
Revenue Growth | -8.48% | 0.66% | 4.46% | 5.54% | 24.36% | 232.84% |
Gross Profit Gross Profit Growth | 133.65 | 151.22 | 161.71 | 141.44 | 94.45 | 97.17 |
Operating Income Operating Income Growth | 36.26 | 50.03 | 30.59 | 14.14 | -32.71 | 14.04 |
Net Income Net Income Growth | 26.61 | 40.69 | 41.48 | 12.97 | -34.76 | 59.83 |
Earnings Per Share EPS Growth | 0.07 | 0.11 | 0.11 | 0.03 | -0.09 | 0.16 |
EPS Growth | -36.19% | -2.40% | 217.25% | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Leasing and Property Services Industry Leasing and Property Services Industry Growth | 26.71 | 28.4 | 27.65 | 22.44 | 31.08 |
Pharmaceutical R&D and Consistency Assessment Pharmaceutical R&D and Consistency Assessment Growth | 187.75 | 203.58 | 191.82 | 183.77 | 140.14 |
Clinical Trial Clinical Trial Growth | 168.16 | 148.95 | 142.63 | 135.89 | 106.7 |
Other Income Other Income Growth | 4.82 | 2.54 | 4.12 | 4.27 | 0.21 |
Total Total Growth | 387.43 | 383.47 | 366.22 | 346.37 | 278.13 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 293.47 | 298.65 | 272.05 | 202.07 | 135.73 | 86.88 |
Total Debt Total Debt Growth | 20 | - | 0.1 | 1.57 | 2.33 | 6.3 |
Net Cash (Debt) Net Cash Growth | 273.47 | 298.65 | 271.95 | 200.5 | 133.4 | 80.59 |
Net Cash Growth | 11.43% | 9.82% | 35.64% | 50.29% | 65.54% | 44.90% |
Net Cash Per Share Net Cash Per Share Growth | 0.71 | 0.78 | 0.71 | 0.53 | 0.35 | 0.21 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 38.05 | 30.42 | 80.29 | 62.08 | 53.18 | 34.72 |
Capital Expenditures CapEx Growth | -14.5 | -18 | -24.61 | -17.24 | -2.41 | -6.04 |
Free Cash Flow Free Cash Flow Growth | 23.55 | 12.42 | 55.68 | 44.84 | 50.77 | 28.68 |
Free Cash Flow Growth | -8.87% | -77.69% | 24.18% | -11.68% | 77.01% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 37.27% | 38.94% | 41.92% | 38.30% | 27.00% | 34.54% |
Operating Margin | 10.11% | 12.88% | 7.93% | 3.83% | -9.35% | 4.99% |
Pretax Margin | 8.24% | 11.37% | 9.56% | 4.46% | -9.18% | 22.10% |
Profit Margin | 7.42% | 10.48% | 10.75% | 3.51% | -9.94% | 21.26% |
FCF Margin | 6.57% | 3.20% | 14.44% | 12.14% | 14.51% | 10.20% |
| Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 0.040 | 0.040 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 0.56% | 0.33% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 103.98 | 115.68 | 60.87 | 227.30 | - | 46.97 |
P/FCF Ratio | 117.56 | 378.87 | 45.34 | 65.76 | 45.52 | 97.96 |
PS Ratio | 7.72 | 12.12 | 6.55 | 7.99 | 6.61 | 9.99 |